Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOXORUBICIN Cause Drug effect incomplete? 91 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 91 reports of Drug effect incomplete have been filed in association with DOXORUBICIN (Doxorubicin Hydrochloride). This represents 0.1% of all adverse event reports for DOXORUBICIN.

91
Reports of Drug effect incomplete with DOXORUBICIN
0.1%
of all DOXORUBICIN reports
26
Deaths
17
Hospitalizations

How Dangerous Is Drug effect incomplete From DOXORUBICIN?

Of the 91 reports, 26 (28.6%) resulted in death, 17 (18.7%) required hospitalization, and 3 (3.3%) were considered life-threatening.

Is Drug effect incomplete Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DOXORUBICIN. However, 91 reports have been filed with the FAERS database.

What Other Side Effects Does DOXORUBICIN Cause?

Febrile neutropenia (8,844) Off label use (7,858) Disease progression (6,165) Neutropenia (5,891) Drug ineffective (4,598) Pyrexia (3,697) Thrombocytopenia (3,638) Anaemia (3,601) Product use in unapproved indication (3,502) Nausea (2,925)

What Other Drugs Cause Drug effect incomplete?

ETANERCEPT (6,815) ADALIMUMAB (4,161) METHOTREXATE (2,718) PREGABALIN (1,600) SECUKINUMAB (1,044) TOFACITINIB (986) LEFLUNOMIDE (681) LORATADINE (679) SILDENAFIL (671) HYDROXYCHLOROQUINE (661)

Which DOXORUBICIN Alternatives Have Lower Drug effect incomplete Risk?

DOXORUBICIN vs DOXYCYCLINE DOXORUBICIN vs DOXYCYCLINE HYCLATE DOXORUBICIN vs DOXYCYCLINE\DOXYCYCLINE HYCLATE DOXORUBICIN vs DOXYLAMINE DOXORUBICIN vs DOXYLAMINE\PYRIDOXINE

Related Pages

DOXORUBICIN Full Profile All Drug effect incomplete Reports All Drugs Causing Drug effect incomplete DOXORUBICIN Demographics